(Alzheimer’s Drug Discovery Foundation) Today, the Alzheimer’s Drug Discovery Foundation (ADDF) announces a new initiative that aims to fast-track the development of digital tools for Alzheimer’s disease and related dementias, as part of its Diagnostics Accelerator biomarkers research program, created in July 2018 by a coalition of philanthropists. This news is discussed in a recently published Notes (link Notes: https://b-gat.es/2JLTXzq) post by Bill Gates. Among the latest philanthropists to join this coalition are Jeff and MacKenzie Bezos.

Original source: https://www.eurekalert.org/pub_releases/2019-04/addf-add040219.php